GHSA-USAID Commitments to Addressing AMR through a One Health Approach through 2024 | U.S. Agency for International Development

One Health and Antimicrobial Resistance | U.S. Agency for International Development

GHSA-USAID Commitments to Addressing AMR through a One Health Approach through 2024 USAID is combating the spread and threat of zoonotic diseases and AMR by supporting the World Health Organization’s Global Action Plan on AMR and the Global Health Security Agenda. The Agency also works with partner governments, academia and the private sector to support the development of national action plans on AMR; monitoring of medicine safety, effectiveness and quality; and supporting AMR and zoonotic disease surveillance systems. Read the full story.

The Monetary Impact of Zoonotic Diseases The use of antimicrobial drugs in humans and animals has expanded such that bacteria, fungi, viruses and parasites resistant to existing antibiotics are emerging at an increasing rate. In many countries, there is minimal regulation and documentation of antimicrobial use in animal production. If we are to prevent antimicrobial-resistant infections in humans and animals, we must establish monitoring systems for AMR and develop regulations that promote the prudent use of antimicrobials in livestock production. Read the full story.

Getting Safe Medicines to the Patients Who Need Them Learn how USAID is looking at Indonesia’s health system comprehensively to understand how to engage communities, strengthen primary health care and improve pharmaceutical quality to mitigate the threat of antimicrobial resistance and the spread of infectious disease. Read the full story.